Herbert Stoeger

2.7k total citations
33 papers, 1.3k citations indexed

About

Herbert Stoeger is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Herbert Stoeger has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 14 papers in Cancer Research and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Herbert Stoeger's work include Cancer Treatment and Pharmacology (8 papers), Estrogen and related hormone effects (8 papers) and Breast Cancer Treatment Studies (8 papers). Herbert Stoeger is often cited by papers focused on Cancer Treatment and Pharmacology (8 papers), Estrogen and related hormone effects (8 papers) and Breast Cancer Treatment Studies (8 papers). Herbert Stoeger collaborates with scholars based in Austria, United States and Germany. Herbert Stoeger's co-authors include Michael Gnant, Richard Greil, Brigitte Mlineritsch, Christian Fesl, Peter Dubsky, Thomas Bauernhofer, R. Jakesz, Guenther G. Steger, Hellmut Samonigg and Michael Seifert and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Herbert Stoeger

33 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Herbert Stoeger Austria 17 848 464 333 281 206 33 1.3k
Sandeep K. Singhal United States 18 592 0.7× 473 1.0× 292 0.9× 195 0.7× 78 0.4× 55 1.2k
Ngan‐Ming Tsang Taiwan 20 553 0.7× 258 0.6× 378 1.1× 200 0.7× 159 0.8× 57 1.3k
Gro Wiedswang Norway 20 1.1k 1.3× 763 1.6× 374 1.1× 338 1.2× 95 0.5× 38 1.7k
Lucien Perey Switzerland 18 444 0.5× 117 0.3× 321 1.0× 157 0.6× 89 0.4× 43 878
Jørn Andersen Denmark 20 461 0.5× 285 0.6× 165 0.5× 107 0.4× 103 0.5× 36 1.0k
W.R. Bezwoda South Africa 16 367 0.4× 196 0.4× 204 0.6× 95 0.3× 87 0.4× 41 891
David Ransom Australia 18 524 0.6× 220 0.5× 583 1.8× 185 0.7× 50 0.2× 36 1.3k
Domenico Sergi Italy 16 359 0.4× 157 0.3× 178 0.5× 166 0.6× 59 0.3× 54 796
A M Ballesta Spain 17 508 0.6× 116 0.3× 351 1.1× 136 0.5× 149 0.7× 32 930
Ewa Kalinka‐Warzocha Poland 18 504 0.6× 169 0.4× 160 0.5× 363 1.3× 69 0.3× 91 944

Countries citing papers authored by Herbert Stoeger

Since Specialization
Citations

This map shows the geographic impact of Herbert Stoeger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herbert Stoeger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herbert Stoeger more than expected).

Fields of papers citing papers by Herbert Stoeger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herbert Stoeger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herbert Stoeger. The network helps show where Herbert Stoeger may publish in the future.

Co-authorship network of co-authors of Herbert Stoeger

This figure shows the co-authorship network connecting the top 25 collaborators of Herbert Stoeger. A scholar is included among the top collaborators of Herbert Stoeger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herbert Stoeger. Herbert Stoeger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thorson, Katherine R., et al.. (2021). Physiological linkage during interactions between doctors and cancer patients. Social Science & Medicine. 284. 114220–114220. 6 indexed citations
2.
Scheipl, Susanne, Iva Brčić, Tina Moser, et al.. (2021). Molecular profiling of soft-tissue sarcomas with FoundationOne® Heme identifies potential targets for sarcoma therapy: a single-centre experience. Therapeutic Advances in Medical Oncology. 13. 4277441157–4277441157. 2 indexed citations
3.
Suppan, Christoph, Daniel Steiner, Florian Posch, et al.. (2020). Safety and clinical evaluation of dual inhibition with pertuzumab and trastuzumab in HER-2-positive breast cancer patients.. Journal of Clinical Oncology. 38(15_suppl). e12520–e12520. 1 indexed citations
4.
Posch, Florian, Christoph Suppan, Robert E. Hammer, et al.. (2019). Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant Therapy. Annals of Surgical Oncology. 26(13). 4274–4283. 31 indexed citations
5.
Schwarzenbacher, Daniela, Christiane Klec, Barbara Pasculli, et al.. (2019). MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors. Breast Cancer Research. 21(1). 20–20. 57 indexed citations
6.
Fiedler, Walter, Herbert Stoeger, Antonella Perotti, et al.. (2018). Phase I study of TrasGEX, a glyco-optimised anti-HER2 monoclonal antibody, in patients with HER2-positive solid tumours. ESMO Open. 3(4). e000381–e000381. 14 indexed citations
7.
Brčić, Luka, Stefanie Stanzer, Ulrike Gruber-Moesenbacher, et al.. (2018). Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lung. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 472(4). 589–598. 23 indexed citations
8.
Posch, Florian, Joanna Szkandera, Konstantin Schlick, et al.. (2018). Large platelet size is associated with poor outcome in patients with metastatic pancreatic cancer. Clinical Chemistry and Laboratory Medicine (CCLM). 57(5). 740–744. 11 indexed citations
9.
Richtig, Georg, Ariane Aigelsreiter, Daniela Schwarzenbacher, et al.. (2017). SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types. PLoS ONE. 12(11). e0187814–e0187814. 46 indexed citations
10.
Lindenmann, Joerg, Luka Brčić, Ellen Heitzer, et al.. (2017). Primary patient-derived lung adenocarcinoma cell culture challenges the association of cancer stem cells with epithelial-to-mesenchymal transition. Scientific Reports. 7(1). 10040–10040. 23 indexed citations
11.
12.
13.
Eisner, Florian, Martin Pichler, Steffen Goletz, Herbert Stoeger, & Hellmut Samonigg. (2015). A glyco-engineered anti-HER2 monoclonal antibody (TrasGEX) induces a long-lasting remission in a patient with HER2 overexpressing metastatic colorectal cancer after failure of all available treatment options. Journal of Clinical Pathology. 68(12). 1044.1–1046. 6 indexed citations
14.
Steger, Guenther G., Richard Greil, Alois Lang, et al.. (2013). Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24). Annals of Oncology. 25(2). 366–371. 57 indexed citations
15.
Gnant, Michael, Brigitte Mlineritsch, Herbert Stoeger, et al.. (2011). Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial. The Lancet Oncology. 12(7). 631–641. 335 indexed citations
16.
Pfeiler, Georg, Robert Königsberg, Christian Fesl, et al.. (2011). Impact of Body Mass Index on the Efficacy of Endocrine Therapy in Premenopausal Patients With Breast Cancer: An Analysis of the Prospective ABCSG-12 Trial. Journal of Clinical Oncology. 29(19). 2653–2659. 153 indexed citations
17.
Stoeger, Herbert, et al.. (2010). Desmoid Tumor Treated with Polychemotherapy Followed by Imatinib: A Case Report and Review of the Literature. Case Reports in Oncology. 3(2). 287–293. 8 indexed citations
18.
Hofmann, G, Thomas Bauernhofer, Peter Krippl, et al.. (2006). Plasmapheresis reverses all side-effects of a cisplatin overdose – a case report and treatment recommendation. BMC Cancer. 6(1). 1–1. 156 indexed citations
19.
20.
Kapp, Karin S., et al.. (2001). Experience with split-course external beam irradiation ± chemotherapy and integrated Ir-192 high-dose-rate brachytherapy in the treatment of primary carcinomas of the anal canal. International Journal of Radiation Oncology*Biology*Physics. 49(4). 997–1005. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sandeep K. Singhal Breakdown of academic impact, for papers by Ngan‐Ming Tsang Breakdown of academic impact, for papers by Gro Wiedswang Breakdown of academic impact, for papers by Lucien Perey Breakdown of academic impact, for papers by Jørn Andersen Breakdown of academic impact, for papers by W.R. Bezwoda Breakdown of academic impact, for papers by David Ransom Breakdown of academic impact, for papers by Domenico Sergi Breakdown of academic impact, for papers by A M Ballesta Breakdown of academic impact, for papers by Ewa Kalinka‐Warzocha
Rankless by CCL
2026